<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02950974</url>
  </required_header>
  <id_info>
    <org_study_id>Stero</org_study_id>
    <nct_id>NCT02950974</nct_id>
  </id_info>
  <brief_title>Change in Serum Chloride Level After Loading Dose of Sterofundin Solution Compared With Normal Saline Solution</brief_title>
  <official_title>Change in Serum Chloride Level After Loading Dose of Sterofundin Solution Compared With Normal Saline Solution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ramathibodi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, crossover, randomized trial to evaluate plasma compositions after loading dose
      of sterofundin solution given to healthy volunteer in the resuscitation manner compared with
      normal saline solution.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      10 healthy volunteers were randomly assigned to receive either normal saline or sterofundin
      for the first solution in dose of 30 mL/kg (max 2 L) over 1 hour. Blood was collected at
      baseline (T0), at 60 minutes (T1), 120 minutes (T2), and 240 minutes (T4) from baseline. Time
      to fist void after initiation of fluid and urine volume were also recorded. After wash-out
      period of at least 1 week, crossover studies were performed with another fluid.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in serum chloride</measure>
    <time_frame>4 hours</time_frame>
    <description>At 0, 1, 2, and 4 hours from initiation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in serum pH</measure>
    <time_frame>4 hours</time_frame>
    <description>At 0, 1, 2, and 4 hours from initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum osmolality</measure>
    <time_frame>4 hours</time_frame>
    <description>At 0, 1, 2, and 4 hours from initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum SID</measure>
    <time_frame>4 hours</time_frame>
    <description>At 0, 1, 2, and 4 hours from initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first void</measure>
    <time_frame>Within 24 hours</time_frame>
    <description>Time in minutes from initiation of fluid to first urination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine volume</measure>
    <time_frame>Within 24 hours</time_frame>
    <description>Volume of first urination in ml</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Change in Serum Chloride Level</condition>
  <arm_group>
    <arm_group_label>NSS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NSS 30 ml/kg (maximum of 2 litres) intravenous load over 1 hour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sterofundin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sterofundin solution 30 ml/kg (maximum of 2 litres) intravenous load over 1 hour</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sterofundin</intervention_name>
    <description>Fluid loading</description>
    <arm_group_label>NSS</arm_group_label>
    <arm_group_label>Sterofundin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NSS</intervention_name>
    <description>Fluid loading</description>
    <arm_group_label>NSS</arm_group_label>
    <arm_group_label>Sterofundin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No underlying disease

          -  LVEF &gt; 0.5

          -  No current medication usage

        Exclusion Criteria:

          -  Pregnancy or lactation

          -  BMI &lt;18 or &gt;25

          -  Fever presented in the past 2 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunthiti Morakul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ramathibodi Hospital</affiliation>
  </overall_official>
  <reference>
    <citation>Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr. 2008 Apr;27(2):179-88. doi: 10.1016/j.clnu.2008.01.008. Epub 2008 Mar 3. Review.</citation>
    <PMID>18313809</PMID>
  </reference>
  <reference>
    <citation>Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyteÂ® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012 Jul;256(1):18-24. doi: 10.1097/SLA.0b013e318256be72. Erratum in: Ann Surg. 2013 Dec;258(6):1118.</citation>
    <PMID>22580944</PMID>
  </reference>
  <reference>
    <citation>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012 Oct 17;308(15):1566-72. doi: 10.1001/jama.2012.13356.</citation>
    <PMID>23073953</PMID>
  </reference>
  <reference>
    <citation>Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution. Intensive Care Med. 2004 Jul;30(7):1432-7. Epub 2004 Feb 28.</citation>
    <PMID>14991093</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <last_update_submitted>October 28, 2016</last_update_submitted>
  <last_update_submitted_qc>October 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ramathibodi Hospital</investigator_affiliation>
    <investigator_full_name>Cherdkiat karnjanarachata</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>sterofundin</keyword>
  <keyword>resuscitation</keyword>
  <keyword>normal saline</keyword>
  <keyword>chloride</keyword>
  <keyword>fluid</keyword>
  <keyword>SID</keyword>
  <keyword>pH</keyword>
  <keyword>osmolality</keyword>
  <keyword>urine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

